Appointments and Second Opinions

Speak with one of our New Patient Coordinators to schedule an appointment, refer a patient or request a second opinion. In urgent cases, we can typically see new patients within 24 hours.

Contact us
Find Clinical Trials

We sponsor and collaborate on clinical trials that break new ground in pediatric cancer and blood disorder treatment. 

Search Pediatric Cancer and Blood Disorder Clinical Trials
Our Affiliations
HMS Affiliate

Dana-Farber/Boston Children's is a teaching affiliate of Harvard Medical School.

Our Affiliations

Tabitha M. Cooney, MD

  • Director, Stop & Shop Family Pediatric Neuro-Oncology Outcomes Clinic
  • Physician
  • Assistant Professor of Pediatrics, Harvard Medical School

Appointment Phone

  • 617-632-3270 (Established Pediatric Patients)
  • 888-733-4662 (New Pediatric Patients)

Fax

  • 617-632-4897

General

Treatment Centers

Discipline

Clinical Interests

Clinical trial design, Disparities, Immunotherapies, Novel therapies, Protocol development, Survivorship

Location

Background

Board Certifications

  • Pediatric Hematology-Oncology, 2017
  • Pediatrics, 2013

Fellowship

  • Lucile Packard Children's Hospital / Stanford University, Pediatric Hematology/Oncology, 2016
  • Lucile Packard Children's Hospital / Stanford University, Pediatric Neuro-Oncology, 2017

Residency

  • Children's Hospital & Research Center Oakland, Pediatrics, 2013

Medical School

  • University of South Florida Morsani College of Medicine, 2010

Biography

Dr. Cooney's research interests include early phase clinical trial development for pediatric central nervous system (CNS) tumors, developmental therapeutics, disparities, and diversity. She has presented her findings, including initial results from a Phase 1 trial in Panobinostat for children with diffuse intrinsic pontine glioma (DIPG) and a DIPG historical cohort, at international and national meetings. Dr. Cooney is actively involved in several pediatric brain tumor consortia, holds leadership committee positions in the Pediatric Neuro-Oncology Consortium (PNOC) and Response Assessment in Pediatric Neuro-Oncology (RAPNO), and is a rising leader in her field.

Physician Video